Scholarlink

Purpose of Review <p>In solid organ transplantation, HLA matching between donor and recipient is an important factor in maintaining graft survival. For this reason, national and international transplantation programmes include HLA matching into their algorithms for deceased donor organ allocation and are used in centres as guidance for maintenance immunosuppression. However, HLA matching explains only a short fraction of long term-outcomes. It is likely that assessing genome-wide compatibility could be the next step towards longer graft survival.</p> Recent Findings <p>Hence in this review, when a donor allele is not present in the recipient, we define this as a genomic mismatch. We describe how the context around a genomic mismatch (i.e. protein expression, surface accessibility, immune recognition, etc.) contributes to an alloimmune risk, which we define as an effective genomic mismatch. As a review focused on the technical aspects, we outline the core components one should consider in analysing the transplant pair through a genome-wide approach, and review current literature based on these core components, contrasting with HLA matching tools.</p> Summary <p>While several studies have explored the role of the genomic mismatches between a donor and recipient, the biological and immunological context of this mismatch is required. Further advancements in this field will benefit greatly from established guidelines and tools. Concluding this review, we evaluate the clinical relevance of these sequencing-based approaches, and whether this increase in scope is valuable for further insights in alloimmunity.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Genomic Donor-Recipient Mismatches in Kidney Transplantation: A Focus on the Techniques and Approaches

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月30日

查看全文
  • Stephen Shoebridge,
  • Andreas Heinzel,
  • Michael Kammer,
  • Adèle Dhuyser,
  • Hugues Richard,
  • Laurent Mesnard,
  • Rainer Oberbauer

摘要

Purpose of Review

In solid organ transplantation, HLA matching between donor and recipient is an important factor in maintaining graft survival. For this reason, national and international transplantation programmes include HLA matching into their algorithms for deceased donor organ allocation and are used in centres as guidance for maintenance immunosuppression. However, HLA matching explains only a short fraction of long term-outcomes. It is likely that assessing genome-wide compatibility could be the next step towards longer graft survival.

Recent Findings

Hence in this review, when a donor allele is not present in the recipient, we define this as a genomic mismatch. We describe how the context around a genomic mismatch (i.e. protein expression, surface accessibility, immune recognition, etc.) contributes to an alloimmune risk, which we define as an effective genomic mismatch. As a review focused on the technical aspects, we outline the core components one should consider in analysing the transplant pair through a genome-wide approach, and review current literature based on these core components, contrasting with HLA matching tools.

Summary

While several studies have explored the role of the genomic mismatches between a donor and recipient, the biological and immunological context of this mismatch is required. Further advancements in this field will benefit greatly from established guidelines and tools. Concluding this review, we evaluate the clinical relevance of these sequencing-based approaches, and whether this increase in scope is valuable for further insights in alloimmunity.